DPP4 inhibitor for memory after stroke in type 2 diabetes
Part of Brain & nervous system, Heart & circulation, Hormones & metabolism clinical trials.
This study tests whether a diabetes drug called a DPP4 inhibitor can help protect memory and thinking after a mild stroke. It is for people with type 2 diabetes who have had a stroke within the last two weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old.
- You have type 2 diabetes that you have had for less than 5 years.
- You have had a mild stroke within the last 2 weeks.
- Your blood sugar control (HbA1c) is between 6.5% and 8.5%.
- You have at least 9 years of education.
- You are not currently taking insulin or certain diabetes drugs (like GLP-1 agonists) and have not taken them in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medication commonly used for diabetes can help patients who had a stroke due to a blocked large artery in the brain. The drug is given as an injection after the standard procedure to remove the blood clot, and researchers will see if it leads to better recovery.
This trial tests whether the diabetes drug canagliflozin can help people with type 2 diabetes and mild cognitive impairment. It may slow down memory and thinking problems while also improving blood sugar control.
This trial tests whether a medicine called an SGLT2 inhibitor, which is usually used for diabetes, can help protect the brain and improve recovery when given soon after a stroke. It is for people who had a stroke within the last 3 days and have moderate to severe symptoms.
This trial tests whether a combination of cilostazol (a blood flow medication) and ginkgo (a herbal supplement) can help protect memory and thinking skills in people over 60 with type 2 diabetes. You may join if your memory is slightly below normal but not severely impaired.
This trial tests whether a diabetes drug called dapagliflozin (also used for heart failure) can help people recover better after a recent heart attack. It's for adults who are already on standard blood thinners and have had a heart attack in the past week.
This trial tests whether a medicine called a GLP-1 receptor agonist (similar to diabetes drugs) can improve recovery after a specific type of bleeding stroke. The study aims to see if this drug can reduce brain swelling and help patients regain function.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.